Sponsored by


UAMS College of Pharmacy Gets Grant to Fight Terrorism

They're developing a drug that is meant to protect a person's intestines and vital organs during a biochemical attack.
LITTLE ROCK, AR - Doctor's at UAMS are developing a drug for FDA approval that has a significant goal to accomplish.

"To be used in the event of a terrorist attack," said Dr. Martin Hauer-Jensen a doctor Pharmaceutical Science in the Division of Radiation Health.

He's developing the medication, along with a team of about 20.

"It's a drug that protects guts from radiation," he said.

It's meant to protect intestines and vital organs during a biochemical terrorist attack.

This team has been given $8.7 million more after an initial $4.7 million for their work.

"It's the largest grant to College of Pharmacy in its 60 year history," said Dr. Hauer-Jensen.

While the drug is being developed to combat terrorism, it also has a second function.

"I hope it benefits them and makes cancer treatment safer and more effective," he said.

It's also helping cancer patients who are going through radiation treatments.

Page: [[$index + 1]]
comments powered by Disqus